nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicardipine—CYP2E1—Fingolimod—multiple sclerosis	0.0931	0.164	CbGbCtD
Nicardipine—CYP2D6—Fingolimod—multiple sclerosis	0.0444	0.0784	CbGbCtD
Nicardipine—CYP2E1—Mitoxantrone—multiple sclerosis	0.0438	0.0773	CbGbCtD
Nicardipine—ABCB1—Methylprednisolone—multiple sclerosis	0.0304	0.0536	CbGbCtD
Nicardipine—CYP3A4—Fingolimod—multiple sclerosis	0.0282	0.0498	CbGbCtD
Nicardipine—CYP2C19—Prednisone—multiple sclerosis	0.0228	0.0402	CbGbCtD
Nicardipine—CYP2E1—Dexamethasone—multiple sclerosis	0.0227	0.0401	CbGbCtD
Nicardipine—CYP2B6—Dexamethasone—multiple sclerosis	0.0224	0.0395	CbGbCtD
Nicardipine—ABCB1—Mitoxantrone—multiple sclerosis	0.0221	0.0391	CbGbCtD
Nicardipine—ABCB1—Betamethasone—multiple sclerosis	0.0197	0.0348	CbGbCtD
Nicardipine—ABCB1—Prednisolone—multiple sclerosis	0.0195	0.0344	CbGbCtD
Nicardipine—ABCB1—Prednisone—multiple sclerosis	0.0184	0.0325	CbGbCtD
Nicardipine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0182	0.0321	CbGbCtD
Nicardipine—CYP3A5—Dexamethasone—multiple sclerosis	0.0176	0.0311	CbGbCtD
Nicardipine—CYP2C8—Dexamethasone—multiple sclerosis	0.017	0.0299	CbGbCtD
Nicardipine—CYP2C19—Dexamethasone—multiple sclerosis	0.0142	0.0251	CbGbCtD
Nicardipine—CYP3A4—Triamcinolone—multiple sclerosis	0.0138	0.0243	CbGbCtD
Nicardipine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0133	0.0234	CbGbCtD
Nicardipine—CYP2C9—Dexamethasone—multiple sclerosis	0.0118	0.0209	CbGbCtD
Nicardipine—CYP3A4—Betamethasone—multiple sclerosis	0.0118	0.0209	CbGbCtD
Nicardipine—CYP3A4—Prednisolone—multiple sclerosis	0.0117	0.0206	CbGbCtD
Nicardipine—ABCB1—Dexamethasone—multiple sclerosis	0.0115	0.0203	CbGbCtD
Nicardipine—CYP3A4—Prednisone—multiple sclerosis	0.011	0.0195	CbGbCtD
Nicardipine—CYP2D6—Dexamethasone—multiple sclerosis	0.0108	0.0191	CbGbCtD
Nicardipine—ABCB1—Methotrexate—multiple sclerosis	0.00923	0.0163	CbGbCtD
Nicardipine—CYP3A4—Dexamethasone—multiple sclerosis	0.00688	0.0121	CbGbCtD
Nicardipine—CALM1—trigeminal nerve—multiple sclerosis	0.00618	0.0578	CbGeAlD
Nicardipine—CALM2—pons—multiple sclerosis	0.00437	0.0409	CbGeAlD
Nicardipine—CALM1—pons—multiple sclerosis	0.00435	0.0407	CbGeAlD
Nicardipine—CALM2—pineal body—multiple sclerosis	0.00312	0.0292	CbGeAlD
Nicardipine—CALM1—pineal body—multiple sclerosis	0.00311	0.029	CbGeAlD
Nicardipine—CALM2—peripheral nervous system—multiple sclerosis	0.00291	0.0272	CbGeAlD
Nicardipine—CALM1—peripheral nervous system—multiple sclerosis	0.00289	0.0271	CbGeAlD
Nicardipine—PDE1A—brainstem—multiple sclerosis	0.00249	0.0233	CbGeAlD
Nicardipine—CALM2—nerve—multiple sclerosis	0.00227	0.0212	CbGeAlD
Nicardipine—CALM1—nerve—multiple sclerosis	0.00226	0.0211	CbGeAlD
Nicardipine—CACNB2—retina—multiple sclerosis	0.00177	0.0165	CbGeAlD
Nicardipine—PDE1A—medulla oblongata—multiple sclerosis	0.00173	0.0162	CbGeAlD
Nicardipine—CACNA2D1—brainstem—multiple sclerosis	0.00172	0.0161	CbGeAlD
Nicardipine—PDE1A—midbrain—multiple sclerosis	0.00158	0.0148	CbGeAlD
Nicardipine—PDE1B—nervous system—multiple sclerosis	0.00155	0.0145	CbGeAlD
Nicardipine—PDE1A—spinal cord—multiple sclerosis	0.00155	0.0145	CbGeAlD
Nicardipine—PDE1B—central nervous system—multiple sclerosis	0.0015	0.014	CbGeAlD
Nicardipine—PDE1B—cerebellum—multiple sclerosis	0.00146	0.0137	CbGeAlD
Nicardipine—PDE1A—nervous system—multiple sclerosis	0.0013	0.0122	CbGeAlD
Nicardipine—PDE1A—central nervous system—multiple sclerosis	0.00125	0.0117	CbGeAlD
Nicardipine—PDE1A—cerebellum—multiple sclerosis	0.00123	0.0115	CbGeAlD
Nicardipine—CALM3—retina—multiple sclerosis	0.0012	0.0112	CbGeAlD
Nicardipine—CHRM4—nervous system—multiple sclerosis	0.00119	0.0111	CbGeAlD
Nicardipine—PDE1B—brain—multiple sclerosis	0.00119	0.0111	CbGeAlD
Nicardipine—CHRM4—central nervous system—multiple sclerosis	0.00115	0.0107	CbGeAlD
Nicardipine—PDE1A—brain—multiple sclerosis	0.000996	0.00931	CbGeAlD
Nicardipine—CALM2—brainstem—multiple sclerosis	0.000973	0.0091	CbGeAlD
Nicardipine—CALM1—brainstem—multiple sclerosis	0.000969	0.00906	CbGeAlD
Nicardipine—CACNB2—nervous system—multiple sclerosis	0.000961	0.00898	CbGeAlD
Nicardipine—CALM2—retina—multiple sclerosis	0.000939	0.00878	CbGeAlD
Nicardipine—CALM1—retina—multiple sclerosis	0.000934	0.00874	CbGeAlD
Nicardipine—CHRM5—nervous system—multiple sclerosis	0.000931	0.00871	CbGeAlD
Nicardipine—CACNB2—central nervous system—multiple sclerosis	0.000925	0.00865	CbGeAlD
Nicardipine—ADRA1A—brainstem—multiple sclerosis	0.000913	0.00853	CbGeAlD
Nicardipine—CHRM4—brain—multiple sclerosis	0.000911	0.00852	CbGeAlD
Nicardipine—CACNB2—cerebellum—multiple sclerosis	0.000904	0.00845	CbGeAlD
Nicardipine—CACNA2D1—nervous system—multiple sclerosis	0.000902	0.00843	CbGeAlD
Nicardipine—CHRM5—central nervous system—multiple sclerosis	0.000897	0.00838	CbGeAlD
Nicardipine—CACNA2D1—central nervous system—multiple sclerosis	0.000868	0.00812	CbGeAlD
Nicardipine—CALM3—medulla oblongata—multiple sclerosis	0.000864	0.00808	CbGeAlD
Nicardipine—ADRA1B—nervous system—multiple sclerosis	0.000851	0.00796	CbGeAlD
Nicardipine—CACNA2D1—cerebellum—multiple sclerosis	0.000849	0.00794	CbGeAlD
Nicardipine—CACNA1D—nervous system—multiple sclerosis	0.00084	0.00785	CbGeAlD
Nicardipine—ADRA1D—nervous system—multiple sclerosis	0.000832	0.00778	CbGeAlD
Nicardipine—ADRA1B—central nervous system—multiple sclerosis	0.000819	0.00766	CbGeAlD
Nicardipine—CACNA1D—central nervous system—multiple sclerosis	0.000808	0.00756	CbGeAlD
Nicardipine—ADRA1D—central nervous system—multiple sclerosis	0.000801	0.00749	CbGeAlD
Nicardipine—CACNA1D—cerebellum—multiple sclerosis	0.00079	0.00739	CbGeAlD
Nicardipine—CALM3—midbrain—multiple sclerosis	0.00079	0.00738	CbGeAlD
Nicardipine—CACNA1C—nervous system—multiple sclerosis	0.000775	0.00725	CbGeAlD
Nicardipine—CALM3—spinal cord—multiple sclerosis	0.00077	0.0072	CbGeAlD
Nicardipine—CACNA1C—central nervous system—multiple sclerosis	0.000746	0.00698	CbGeAlD
Nicardipine—CACNB2—brain—multiple sclerosis	0.000734	0.00686	CbGeAlD
Nicardipine—CACNA1C—cerebellum—multiple sclerosis	0.000729	0.00682	CbGeAlD
Nicardipine—CHRM5—brain—multiple sclerosis	0.000712	0.00666	CbGeAlD
Nicardipine—CACNA2D1—brain—multiple sclerosis	0.000689	0.00645	CbGeAlD
Nicardipine—CALM2—medulla oblongata—multiple sclerosis	0.000678	0.00634	CbGeAlD
Nicardipine—CALM1—medulla oblongata—multiple sclerosis	0.000675	0.00631	CbGeAlD
Nicardipine—ADRA1B—brain—multiple sclerosis	0.00065	0.00608	CbGeAlD
Nicardipine—CACNA1D—brain—multiple sclerosis	0.000642	0.006	CbGeAlD
Nicardipine—CHRM2—nervous system—multiple sclerosis	0.000639	0.00598	CbGeAlD
Nicardipine—ADRA1D—brain—multiple sclerosis	0.000636	0.00595	CbGeAlD
Nicardipine—CALM2—midbrain—multiple sclerosis	0.00062	0.0058	CbGeAlD
Nicardipine—CALM1—midbrain—multiple sclerosis	0.000617	0.00577	CbGeAlD
Nicardipine—CHRM2—central nervous system—multiple sclerosis	0.000616	0.00576	CbGeAlD
Nicardipine—CALM3—cerebellum—multiple sclerosis	0.000611	0.00571	CbGeAlD
Nicardipine—CALM2—spinal cord—multiple sclerosis	0.000605	0.00566	CbGeAlD
Nicardipine—CALM1—spinal cord—multiple sclerosis	0.000602	0.00563	CbGeAlD
Nicardipine—CACNA1C—brain—multiple sclerosis	0.000592	0.00554	CbGeAlD
Nicardipine—CHRM1—nervous system—multiple sclerosis	0.000582	0.00544	CbGeAlD
Nicardipine—CHRM1—central nervous system—multiple sclerosis	0.00056	0.00524	CbGeAlD
Nicardipine—CYP2D6—brainstem—multiple sclerosis	0.000537	0.00503	CbGeAlD
Nicardipine—CHRM3—nervous system—multiple sclerosis	0.000521	0.00487	CbGeAlD
Nicardipine—CALM2—nervous system—multiple sclerosis	0.00051	0.00477	CbGeAlD
Nicardipine—CALM1—nervous system—multiple sclerosis	0.000507	0.00474	CbGeAlD
Nicardipine—CHRM3—central nervous system—multiple sclerosis	0.000501	0.00469	CbGeAlD
Nicardipine—CALM3—brain—multiple sclerosis	0.000496	0.00464	CbGeAlD
Nicardipine—CALM2—central nervous system—multiple sclerosis	0.000491	0.00459	CbGeAlD
Nicardipine—CHRM2—brain—multiple sclerosis	0.000489	0.00457	CbGeAlD
Nicardipine—CALM1—central nervous system—multiple sclerosis	0.000489	0.00457	CbGeAlD
Nicardipine—CALM2—cerebellum—multiple sclerosis	0.00048	0.00449	CbGeAlD
Nicardipine—ADRA1A—nervous system—multiple sclerosis	0.000478	0.00447	CbGeAlD
Nicardipine—CALM1—cerebellum—multiple sclerosis	0.000478	0.00446	CbGeAlD
Nicardipine—CYP2E1—medulla oblongata—multiple sclerosis	0.000473	0.00443	CbGeAlD
Nicardipine—ADRA1A—central nervous system—multiple sclerosis	0.00046	0.0043	CbGeAlD
Nicardipine—ADRA1A—cerebellum—multiple sclerosis	0.00045	0.00421	CbGeAlD
Nicardipine—CHRM1—brain—multiple sclerosis	0.000445	0.00416	CbGeAlD
Nicardipine—CYP2E1—spinal cord—multiple sclerosis	0.000422	0.00395	CbGeAlD
Nicardipine—CHRM3—brain—multiple sclerosis	0.000398	0.00372	CbGeAlD
Nicardipine—CALM2—brain—multiple sclerosis	0.00039	0.00364	CbGeAlD
Nicardipine—CALM1—brain—multiple sclerosis	0.000388	0.00363	CbGeAlD
Nicardipine—CYP2B6—nervous system—multiple sclerosis	0.000379	0.00354	CbGeAlD
Nicardipine—ABCB1—retina—multiple sclerosis	0.000373	0.00349	CbGeAlD
Nicardipine—ADRA1A—brain—multiple sclerosis	0.000365	0.00342	CbGeAlD
Nicardipine—CYP2B6—central nervous system—multiple sclerosis	0.000365	0.00341	CbGeAlD
Nicardipine—CYP2E1—nervous system—multiple sclerosis	0.000356	0.00333	CbGeAlD
Nicardipine—CYP2E1—central nervous system—multiple sclerosis	0.000342	0.0032	CbGeAlD
Nicardipine—CYP2E1—cerebellum—multiple sclerosis	0.000335	0.00313	CbGeAlD
Nicardipine—CYP2C8—brain—multiple sclerosis	0.000323	0.00302	CbGeAlD
Nicardipine—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000318	0.00246	CcSEcCtD
Nicardipine—Malaise—Prednisolone—multiple sclerosis	0.000316	0.00245	CcSEcCtD
Nicardipine—Nausea—Cladribine—multiple sclerosis	0.000315	0.00244	CcSEcCtD
Nicardipine—Vertigo—Prednisolone—multiple sclerosis	0.000315	0.00244	CcSEcCtD
Nicardipine—Syncope—Prednisolone—multiple sclerosis	0.000314	0.00243	CcSEcCtD
Nicardipine—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000313	0.00242	CcSEcCtD
Nicardipine—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000311	0.00241	CcSEcCtD
Nicardipine—Somnolence—Mitoxantrone—multiple sclerosis	0.00031	0.0024	CcSEcCtD
Nicardipine—Loss of consciousness—Prednisolone—multiple sclerosis	0.000308	0.00238	CcSEcCtD
Nicardipine—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000307	0.00238	CcSEcCtD
Nicardipine—Hypertension—Prednisolone—multiple sclerosis	0.000302	0.00234	CcSEcCtD
Nicardipine—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000299	0.00232	CcSEcCtD
Nicardipine—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000298	0.00231	CcSEcCtD
Nicardipine—Pain—Mitoxantrone—multiple sclerosis	0.000298	0.00231	CcSEcCtD
Nicardipine—Constipation—Mitoxantrone—multiple sclerosis	0.000298	0.00231	CcSEcCtD
Nicardipine—Diarrhoea—Azathioprine—multiple sclerosis	0.000295	0.00228	CcSEcCtD
Nicardipine—Discomfort—Prednisolone—multiple sclerosis	0.000295	0.00228	CcSEcCtD
Nicardipine—Malaise—Triamcinolone—multiple sclerosis	0.000291	0.00225	CcSEcCtD
Nicardipine—Malaise—Methylprednisolone—multiple sclerosis	0.00029	0.00225	CcSEcCtD
Nicardipine—CYP2B6—brain—multiple sclerosis	0.00029	0.00271	CbGeAlD
Nicardipine—Vertigo—Triamcinolone—multiple sclerosis	0.000289	0.00224	CcSEcCtD
Nicardipine—Syncope—Triamcinolone—multiple sclerosis	0.000289	0.00224	CcSEcCtD
Nicardipine—Vertigo—Methylprednisolone—multiple sclerosis	0.000289	0.00224	CcSEcCtD
Nicardipine—Syncope—Methylprednisolone—multiple sclerosis	0.000288	0.00223	CcSEcCtD
Nicardipine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000287	0.00222	CcSEcCtD
Nicardipine—CYP3A4—nervous system—multiple sclerosis	0.000286	0.00268	CbGeAlD
Nicardipine—Oedema—Prednisolone—multiple sclerosis	0.000286	0.00221	CcSEcCtD
Nicardipine—Dizziness—Azathioprine—multiple sclerosis	0.000285	0.00221	CcSEcCtD
Nicardipine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000285	0.00221	CcSEcCtD
Nicardipine—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000283	0.00219	CcSEcCtD
Nicardipine—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000283	0.00219	CcSEcCtD
Nicardipine—CYP2D6—nervous system—multiple sclerosis	0.000282	0.00263	CbGeAlD
Nicardipine—Shock—Prednisolone—multiple sclerosis	0.000281	0.00218	CcSEcCtD
Nicardipine—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000281	0.00218	CcSEcCtD
Nicardipine—Tachycardia—Prednisolone—multiple sclerosis	0.000279	0.00216	CcSEcCtD
Nicardipine—Hypertension—Triamcinolone—multiple sclerosis	0.000278	0.00215	CcSEcCtD
Nicardipine—Hypertension—Methylprednisolone—multiple sclerosis	0.000278	0.00215	CcSEcCtD
Nicardipine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000276	0.00214	CcSEcCtD
Nicardipine—CYP3A4—central nervous system—multiple sclerosis	0.000276	0.00258	CbGeAlD
Nicardipine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000275	0.00213	CcSEcCtD
Nicardipine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000275	0.00213	CcSEcCtD
Nicardipine—Myalgia—Triamcinolone—multiple sclerosis	0.000274	0.00212	CcSEcCtD
Nicardipine—Vomiting—Azathioprine—multiple sclerosis	0.000274	0.00212	CcSEcCtD
Nicardipine—Arthralgia—Methylprednisolone—multiple sclerosis	0.000274	0.00212	CcSEcCtD
Nicardipine—Myalgia—Methylprednisolone—multiple sclerosis	0.000274	0.00212	CcSEcCtD
Nicardipine—Anxiety—Methylprednisolone—multiple sclerosis	0.000273	0.00211	CcSEcCtD
Nicardipine—CYP2E1—brain—multiple sclerosis	0.000272	0.00254	CbGeAlD
Nicardipine—Rash—Azathioprine—multiple sclerosis	0.000272	0.00211	CcSEcCtD
Nicardipine—Dermatitis—Azathioprine—multiple sclerosis	0.000272	0.0021	CcSEcCtD
Nicardipine—Flushing—Prednisone—multiple sclerosis	0.000271	0.0021	CcSEcCtD
Nicardipine—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000271	0.0021	CcSEcCtD
Nicardipine—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000271	0.0021	CcSEcCtD
Nicardipine—CYP2D6—central nervous system—multiple sclerosis	0.000271	0.00254	CbGeAlD
Nicardipine—Discomfort—Triamcinolone—multiple sclerosis	0.000271	0.0021	CcSEcCtD
Nicardipine—Discomfort—Methylprednisolone—multiple sclerosis	0.00027	0.00209	CcSEcCtD
Nicardipine—Headache—Azathioprine—multiple sclerosis	0.00027	0.00209	CcSEcCtD
Nicardipine—ABCB1—medulla oblongata—multiple sclerosis	0.00027	0.00252	CbGeAlD
Nicardipine—Dry mouth—Triamcinolone—multiple sclerosis	0.000268	0.00208	CcSEcCtD
Nicardipine—CYP2D6—cerebellum—multiple sclerosis	0.000265	0.00248	CbGeAlD
Nicardipine—Conjunctivitis—Methotrexate—multiple sclerosis	0.000265	0.00205	CcSEcCtD
Nicardipine—Confusional state—Methylprednisolone—multiple sclerosis	0.000265	0.00205	CcSEcCtD
Nicardipine—Malaise—Dexamethasone—multiple sclerosis	0.000264	0.00204	CcSEcCtD
Nicardipine—Malaise—Betamethasone—multiple sclerosis	0.000264	0.00204	CcSEcCtD
Nicardipine—Oedema—Triamcinolone—multiple sclerosis	0.000263	0.00204	CcSEcCtD
Nicardipine—Vertigo—Betamethasone—multiple sclerosis	0.000263	0.00203	CcSEcCtD
Nicardipine—Vertigo—Dexamethasone—multiple sclerosis	0.000263	0.00203	CcSEcCtD
Nicardipine—Syncope—Betamethasone—multiple sclerosis	0.000262	0.00203	CcSEcCtD
Nicardipine—Syncope—Dexamethasone—multiple sclerosis	0.000262	0.00203	CcSEcCtD
Nicardipine—Infection—Triamcinolone—multiple sclerosis	0.000261	0.00202	CcSEcCtD
Nicardipine—Sweating—Methotrexate—multiple sclerosis	0.000261	0.00202	CcSEcCtD
Nicardipine—Infection—Methylprednisolone—multiple sclerosis	0.000261	0.00202	CcSEcCtD
Nicardipine—Haematuria—Methotrexate—multiple sclerosis	0.00026	0.00201	CcSEcCtD
Nicardipine—Shock—Triamcinolone—multiple sclerosis	0.000259	0.002	CcSEcCtD
Nicardipine—Insomnia—Prednisolone—multiple sclerosis	0.000259	0.002	CcSEcCtD
Nicardipine—Shock—Methylprednisolone—multiple sclerosis	0.000258	0.002	CcSEcCtD
Nicardipine—Loss of consciousness—Betamethasone—multiple sclerosis	0.000257	0.00199	CcSEcCtD
Nicardipine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000257	0.00199	CcSEcCtD
Nicardipine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000257	0.00199	CcSEcCtD
Nicardipine—Paraesthesia—Prednisolone—multiple sclerosis	0.000257	0.00199	CcSEcCtD
Nicardipine—Tachycardia—Triamcinolone—multiple sclerosis	0.000257	0.00199	CcSEcCtD
Nicardipine—Nausea—Azathioprine—multiple sclerosis	0.000256	0.00198	CcSEcCtD
Nicardipine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000256	0.00198	CcSEcCtD
Nicardipine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000254	0.00197	CcSEcCtD
Nicardipine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000254	0.00196	CcSEcCtD
Nicardipine—Hypertension—Dexamethasone—multiple sclerosis	0.000252	0.00195	CcSEcCtD
Nicardipine—Hypertension—Betamethasone—multiple sclerosis	0.000252	0.00195	CcSEcCtD
Nicardipine—Asthenia—Mitoxantrone—multiple sclerosis	0.00025	0.00194	CcSEcCtD
Nicardipine—Myalgia—Betamethasone—multiple sclerosis	0.000249	0.00193	CcSEcCtD
Nicardipine—Myalgia—Dexamethasone—multiple sclerosis	0.000249	0.00193	CcSEcCtD
Nicardipine—Anxiety—Dexamethasone—multiple sclerosis	0.000248	0.00192	CcSEcCtD
Nicardipine—Anxiety—Betamethasone—multiple sclerosis	0.000248	0.00192	CcSEcCtD
Nicardipine—ABCB1—midbrain—multiple sclerosis	0.000246	0.0023	CbGeAlD
Nicardipine—Discomfort—Dexamethasone—multiple sclerosis	0.000246	0.0019	CcSEcCtD
Nicardipine—Discomfort—Betamethasone—multiple sclerosis	0.000246	0.0019	CcSEcCtD
Nicardipine—Hypotension—Methylprednisolone—multiple sclerosis	0.000245	0.0019	CcSEcCtD
Nicardipine—Pain—Prednisolone—multiple sclerosis	0.000244	0.00189	CcSEcCtD
Nicardipine—ABCB1—spinal cord—multiple sclerosis	0.00024	0.00225	CbGeAlD
Nicardipine—Vision blurred—Prednisone—multiple sclerosis	0.00024	0.00186	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.00024	0.00186	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000239	0.00185	CcSEcCtD
Nicardipine—Oedema—Dexamethasone—multiple sclerosis	0.000239	0.00185	CcSEcCtD
Nicardipine—Oedema—Betamethasone—multiple sclerosis	0.000239	0.00185	CcSEcCtD
Nicardipine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000238	0.00185	CcSEcCtD
Nicardipine—Insomnia—Triamcinolone—multiple sclerosis	0.000238	0.00184	CcSEcCtD
Nicardipine—Insomnia—Methylprednisolone—multiple sclerosis	0.000237	0.00184	CcSEcCtD
Nicardipine—Infection—Dexamethasone—multiple sclerosis	0.000237	0.00184	CcSEcCtD
Nicardipine—Infection—Betamethasone—multiple sclerosis	0.000237	0.00184	CcSEcCtD
Nicardipine—Ill-defined disorder—Prednisone—multiple sclerosis	0.000236	0.00183	CcSEcCtD
Nicardipine—Paraesthesia—Triamcinolone—multiple sclerosis	0.000236	0.00183	CcSEcCtD
Nicardipine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000236	0.00182	CcSEcCtD
Nicardipine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000236	0.00182	CcSEcCtD
Nicardipine—Visual impairment—Methotrexate—multiple sclerosis	0.000236	0.00182	CcSEcCtD
Nicardipine—Shock—Betamethasone—multiple sclerosis	0.000235	0.00182	CcSEcCtD
Nicardipine—Shock—Dexamethasone—multiple sclerosis	0.000235	0.00182	CcSEcCtD
Nicardipine—Dyspnoea—Triamcinolone—multiple sclerosis	0.000234	0.00182	CcSEcCtD
Nicardipine—Agitation—Prednisone—multiple sclerosis	0.000234	0.00181	CcSEcCtD
Nicardipine—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000234	0.00181	CcSEcCtD
Nicardipine—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000234	0.00181	CcSEcCtD
Nicardipine—Tachycardia—Betamethasone—multiple sclerosis	0.000233	0.0018	CcSEcCtD
Nicardipine—Tachycardia—Dexamethasone—multiple sclerosis	0.000233	0.0018	CcSEcCtD
Nicardipine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000231	0.00179	CcSEcCtD
Nicardipine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000231	0.00179	CcSEcCtD
Nicardipine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000231	0.00179	CcSEcCtD
Nicardipine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000231	0.00179	CcSEcCtD
Nicardipine—Malaise—Prednisone—multiple sclerosis	0.00023	0.00178	CcSEcCtD
Nicardipine—Vertigo—Prednisone—multiple sclerosis	0.000229	0.00177	CcSEcCtD
Nicardipine—Syncope—Prednisone—multiple sclerosis	0.000228	0.00177	CcSEcCtD
Nicardipine—Tinnitus—Methotrexate—multiple sclerosis	0.000228	0.00177	CcSEcCtD
Nicardipine—Pain—Triamcinolone—multiple sclerosis	0.000225	0.00174	CcSEcCtD
Nicardipine—Loss of consciousness—Prednisone—multiple sclerosis	0.000224	0.00173	CcSEcCtD
Nicardipine—Hypotension—Dexamethasone—multiple sclerosis	0.000223	0.00173	CcSEcCtD
Nicardipine—Hypotension—Betamethasone—multiple sclerosis	0.000223	0.00173	CcSEcCtD
Nicardipine—Vomiting—Mitoxantrone—multiple sclerosis	0.000222	0.00172	CcSEcCtD
Nicardipine—Hypertension—Prednisone—multiple sclerosis	0.00022	0.0017	CcSEcCtD
Nicardipine—Rash—Mitoxantrone—multiple sclerosis	0.00022	0.0017	CcSEcCtD
Nicardipine—Dermatitis—Mitoxantrone—multiple sclerosis	0.00022	0.0017	CcSEcCtD
Nicardipine—Headache—Mitoxantrone—multiple sclerosis	0.000218	0.00169	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000217	0.00168	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000217	0.00168	CcSEcCtD
Nicardipine—Myalgia—Prednisone—multiple sclerosis	0.000217	0.00168	CcSEcCtD
Nicardipine—Arthralgia—Prednisone—multiple sclerosis	0.000217	0.00168	CcSEcCtD
Nicardipine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000217	0.00168	CcSEcCtD
Nicardipine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000216	0.00167	CcSEcCtD
Nicardipine—Anxiety—Prednisone—multiple sclerosis	0.000216	0.00167	CcSEcCtD
Nicardipine—Insomnia—Dexamethasone—multiple sclerosis	0.000216	0.00167	CcSEcCtD
Nicardipine—Insomnia—Betamethasone—multiple sclerosis	0.000216	0.00167	CcSEcCtD
Nicardipine—CYP2D6—brain—multiple sclerosis	0.000215	0.00201	CbGeAlD
Nicardipine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000215	0.00166	CcSEcCtD
Nicardipine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000214	0.00166	CcSEcCtD
Nicardipine—Paraesthesia—Betamethasone—multiple sclerosis	0.000214	0.00166	CcSEcCtD
Nicardipine—Discomfort—Prednisone—multiple sclerosis	0.000214	0.00166	CcSEcCtD
Nicardipine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000211	0.00163	CcSEcCtD
Nicardipine—Dyspepsia—Dexamethasone—multiple sclerosis	0.00021	0.00163	CcSEcCtD
Nicardipine—Dyspepsia—Betamethasone—multiple sclerosis	0.00021	0.00163	CcSEcCtD
Nicardipine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000208	0.00161	CcSEcCtD
Nicardipine—Oedema—Prednisone—multiple sclerosis	0.000208	0.00161	CcSEcCtD
Nicardipine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000207	0.00161	CcSEcCtD
Nicardipine—Nausea—Mitoxantrone—multiple sclerosis	0.000207	0.0016	CcSEcCtD
Nicardipine—Infection—Prednisone—multiple sclerosis	0.000206	0.0016	CcSEcCtD
Nicardipine—Shock—Prednisone—multiple sclerosis	0.000204	0.00158	CcSEcCtD
Nicardipine—Pain—Betamethasone—multiple sclerosis	0.000204	0.00158	CcSEcCtD
Nicardipine—Pain—Dexamethasone—multiple sclerosis	0.000204	0.00158	CcSEcCtD
Nicardipine—Tachycardia—Prednisone—multiple sclerosis	0.000203	0.00157	CcSEcCtD
Nicardipine—ABCB1—nervous system—multiple sclerosis	0.000203	0.00189	CbGeAlD
Nicardipine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000201	0.00156	CcSEcCtD
Nicardipine—Vision blurred—Methotrexate—multiple sclerosis	0.000201	0.00155	CcSEcCtD
Nicardipine—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000197	0.00153	CcSEcCtD
Nicardipine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000197	0.00152	CcSEcCtD
Nicardipine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000197	0.00152	CcSEcCtD
Nicardipine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000195	0.00151	CcSEcCtD
Nicardipine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000195	0.00151	CcSEcCtD
Nicardipine—ABCB1—central nervous system—multiple sclerosis	0.000195	0.00182	CbGeAlD
Nicardipine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000194	0.0015	CcSEcCtD
Nicardipine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000193	0.0015	CcSEcCtD
Nicardipine—Malaise—Methotrexate—multiple sclerosis	0.000192	0.00149	CcSEcCtD
Nicardipine—Vertigo—Methotrexate—multiple sclerosis	0.000191	0.00148	CcSEcCtD
Nicardipine—ABCB1—cerebellum—multiple sclerosis	0.000191	0.00178	CbGeAlD
Nicardipine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000189	0.00147	CcSEcCtD
Nicardipine—Dizziness—Prednisolone—multiple sclerosis	0.000189	0.00146	CcSEcCtD
Nicardipine—Asthenia—Triamcinolone—multiple sclerosis	0.000189	0.00146	CcSEcCtD
Nicardipine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000189	0.00146	CcSEcCtD
Nicardipine—Body temperature increased—Betamethasone—multiple sclerosis	0.000189	0.00146	CcSEcCtD
Nicardipine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000189	0.00146	CcSEcCtD
Nicardipine—Abdominal pain—Betamethasone—multiple sclerosis	0.000189	0.00146	CcSEcCtD
Nicardipine—Asthenia—Methylprednisolone—multiple sclerosis	0.000188	0.00146	CcSEcCtD
Nicardipine—Insomnia—Prednisone—multiple sclerosis	0.000188	0.00146	CcSEcCtD
Nicardipine—Paraesthesia—Prednisone—multiple sclerosis	0.000187	0.00145	CcSEcCtD
Nicardipine—Dyspepsia—Prednisone—multiple sclerosis	0.000183	0.00142	CcSEcCtD
Nicardipine—Arthralgia—Methotrexate—multiple sclerosis	0.000181	0.0014	CcSEcCtD
Nicardipine—Chest pain—Methotrexate—multiple sclerosis	0.000181	0.0014	CcSEcCtD
Nicardipine—Myalgia—Methotrexate—multiple sclerosis	0.000181	0.0014	CcSEcCtD
Nicardipine—Rash—Prednisolone—multiple sclerosis	0.00018	0.0014	CcSEcCtD
Nicardipine—Dermatitis—Prednisolone—multiple sclerosis	0.00018	0.0014	CcSEcCtD
Nicardipine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000179	0.00139	CcSEcCtD
Nicardipine—Headache—Prednisolone—multiple sclerosis	0.000179	0.00139	CcSEcCtD
Nicardipine—Discomfort—Methotrexate—multiple sclerosis	0.000179	0.00139	CcSEcCtD
Nicardipine—Constipation—Prednisone—multiple sclerosis	0.000178	0.00138	CcSEcCtD
Nicardipine—Confusional state—Methotrexate—multiple sclerosis	0.000175	0.00136	CcSEcCtD
Nicardipine—Dizziness—Triamcinolone—multiple sclerosis	0.000174	0.00135	CcSEcCtD
Nicardipine—Dizziness—Methylprednisolone—multiple sclerosis	0.000173	0.00134	CcSEcCtD
Nicardipine—Infection—Methotrexate—multiple sclerosis	0.000173	0.00134	CcSEcCtD
Nicardipine—Feeling abnormal—Prednisone—multiple sclerosis	0.000171	0.00133	CcSEcCtD
Nicardipine—Asthenia—Dexamethasone—multiple sclerosis	0.000171	0.00133	CcSEcCtD
Nicardipine—Asthenia—Betamethasone—multiple sclerosis	0.000171	0.00133	CcSEcCtD
Nicardipine—Thrombocytopenia—Methotrexate—multiple sclerosis	0.00017	0.00132	CcSEcCtD
Nicardipine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.00017	0.00132	CcSEcCtD
Nicardipine—Nausea—Prednisolone—multiple sclerosis	0.00017	0.00132	CcSEcCtD
Nicardipine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000168	0.0013	CcSEcCtD
Nicardipine—Vomiting—Triamcinolone—multiple sclerosis	0.000167	0.00129	CcSEcCtD
Nicardipine—Vomiting—Methylprednisolone—multiple sclerosis	0.000167	0.00129	CcSEcCtD
Nicardipine—Rash—Triamcinolone—multiple sclerosis	0.000166	0.00128	CcSEcCtD
Nicardipine—Dermatitis—Triamcinolone—multiple sclerosis	0.000166	0.00128	CcSEcCtD
Nicardipine—Rash—Methylprednisolone—multiple sclerosis	0.000165	0.00128	CcSEcCtD
Nicardipine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000165	0.00128	CcSEcCtD
Nicardipine—Headache—Triamcinolone—multiple sclerosis	0.000165	0.00128	CcSEcCtD
Nicardipine—Headache—Methylprednisolone—multiple sclerosis	0.000164	0.00127	CcSEcCtD
Nicardipine—Abdominal pain—Prednisone—multiple sclerosis	0.000164	0.00127	CcSEcCtD
Nicardipine—Body temperature increased—Prednisone—multiple sclerosis	0.000164	0.00127	CcSEcCtD
Nicardipine—Diarrhoea—Betamethasone—multiple sclerosis	0.000163	0.00126	CcSEcCtD
Nicardipine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000163	0.00126	CcSEcCtD
Nicardipine—Hypotension—Methotrexate—multiple sclerosis	0.000162	0.00126	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000158	0.00123	CcSEcCtD
Nicardipine—Dizziness—Betamethasone—multiple sclerosis	0.000158	0.00122	CcSEcCtD
Nicardipine—Dizziness—Dexamethasone—multiple sclerosis	0.000158	0.00122	CcSEcCtD
Nicardipine—Insomnia—Methotrexate—multiple sclerosis	0.000157	0.00122	CcSEcCtD
Nicardipine—Nausea—Triamcinolone—multiple sclerosis	0.000156	0.00121	CcSEcCtD
Nicardipine—Paraesthesia—Methotrexate—multiple sclerosis	0.000156	0.00121	CcSEcCtD
Nicardipine—Nausea—Methylprednisolone—multiple sclerosis	0.000156	0.00121	CcSEcCtD
Nicardipine—ABCB1—brain—multiple sclerosis	0.000155	0.00145	CbGeAlD
Nicardipine—Dyspnoea—Methotrexate—multiple sclerosis	0.000155	0.0012	CcSEcCtD
Nicardipine—Somnolence—Methotrexate—multiple sclerosis	0.000154	0.0012	CcSEcCtD
Nicardipine—Hypersensitivity—Prednisone—multiple sclerosis	0.000153	0.00119	CcSEcCtD
Nicardipine—Dyspepsia—Methotrexate—multiple sclerosis	0.000153	0.00118	CcSEcCtD
Nicardipine—Vomiting—Dexamethasone—multiple sclerosis	0.000152	0.00117	CcSEcCtD
Nicardipine—Vomiting—Betamethasone—multiple sclerosis	0.000152	0.00117	CcSEcCtD
Nicardipine—Rash—Dexamethasone—multiple sclerosis	0.00015	0.00117	CcSEcCtD
Nicardipine—Rash—Betamethasone—multiple sclerosis	0.00015	0.00117	CcSEcCtD
Nicardipine—Dermatitis—Dexamethasone—multiple sclerosis	0.00015	0.00116	CcSEcCtD
Nicardipine—Dermatitis—Betamethasone—multiple sclerosis	0.00015	0.00116	CcSEcCtD
Nicardipine—Headache—Dexamethasone—multiple sclerosis	0.000149	0.00116	CcSEcCtD
Nicardipine—Headache—Betamethasone—multiple sclerosis	0.000149	0.00116	CcSEcCtD
Nicardipine—Asthenia—Prednisone—multiple sclerosis	0.000149	0.00115	CcSEcCtD
Nicardipine—Pain—Methotrexate—multiple sclerosis	0.000148	0.00115	CcSEcCtD
Nicardipine—Feeling abnormal—Methotrexate—multiple sclerosis	0.000143	0.00111	CcSEcCtD
Nicardipine—Diarrhoea—Prednisone—multiple sclerosis	0.000142	0.0011	CcSEcCtD
Nicardipine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000142	0.0011	CcSEcCtD
Nicardipine—Nausea—Betamethasone—multiple sclerosis	0.000142	0.0011	CcSEcCtD
Nicardipine—Nausea—Dexamethasone—multiple sclerosis	0.000142	0.0011	CcSEcCtD
Nicardipine—Dizziness—Prednisone—multiple sclerosis	0.000137	0.00106	CcSEcCtD
Nicardipine—Abdominal pain—Methotrexate—multiple sclerosis	0.000137	0.00106	CcSEcCtD
Nicardipine—Body temperature increased—Methotrexate—multiple sclerosis	0.000137	0.00106	CcSEcCtD
Nicardipine—Vomiting—Prednisone—multiple sclerosis	0.000132	0.00102	CcSEcCtD
Nicardipine—Rash—Prednisone—multiple sclerosis	0.000131	0.00101	CcSEcCtD
Nicardipine—Dermatitis—Prednisone—multiple sclerosis	0.000131	0.00101	CcSEcCtD
Nicardipine—Headache—Prednisone—multiple sclerosis	0.00013	0.00101	CcSEcCtD
Nicardipine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000128	0.000991	CcSEcCtD
Nicardipine—Asthenia—Methotrexate—multiple sclerosis	0.000125	0.000965	CcSEcCtD
Nicardipine—Nausea—Prednisone—multiple sclerosis	0.000123	0.000956	CcSEcCtD
Nicardipine—Diarrhoea—Methotrexate—multiple sclerosis	0.000119	0.00092	CcSEcCtD
Nicardipine—Dizziness—Methotrexate—multiple sclerosis	0.000115	0.000889	CcSEcCtD
Nicardipine—Vomiting—Methotrexate—multiple sclerosis	0.00011	0.000855	CcSEcCtD
Nicardipine—Rash—Methotrexate—multiple sclerosis	0.000109	0.000848	CcSEcCtD
Nicardipine—Dermatitis—Methotrexate—multiple sclerosis	0.000109	0.000847	CcSEcCtD
Nicardipine—Headache—Methotrexate—multiple sclerosis	0.000109	0.000843	CcSEcCtD
Nicardipine—Nausea—Methotrexate—multiple sclerosis	0.000103	0.000799	CcSEcCtD
Nicardipine—CALM1—Signaling by GPCR—TYK2—multiple sclerosis	8.46e-06	4.28e-05	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—TGFB1—multiple sclerosis	8.45e-06	4.28e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—CD80—multiple sclerosis	8.45e-06	4.27e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—CD80—multiple sclerosis	8.45e-06	4.27e-05	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—MAPK1—multiple sclerosis	8.44e-06	4.27e-05	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—MAPK1—multiple sclerosis	8.44e-06	4.27e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CD86—multiple sclerosis	8.38e-06	4.24e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—APOE—multiple sclerosis	8.31e-06	4.21e-05	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—POMC—multiple sclerosis	8.3e-06	4.2e-05	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—MAPK1—multiple sclerosis	8.29e-06	4.19e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—TYK2—multiple sclerosis	8.26e-06	4.18e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CCL5—multiple sclerosis	8.25e-06	4.18e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—APOE—multiple sclerosis	8.14e-06	4.12e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—APOE—multiple sclerosis	8.13e-06	4.11e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—CD80—multiple sclerosis	8.12e-06	4.11e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CD86—multiple sclerosis	8.11e-06	4.1e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CD86—multiple sclerosis	8.11e-06	4.1e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—APOE—multiple sclerosis	8.11e-06	4.1e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—APOE—multiple sclerosis	8.09e-06	4.09e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—APOE—multiple sclerosis	8.08e-06	4.09e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—APOE—multiple sclerosis	8e-06	4.05e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—TYK2—multiple sclerosis	7.99e-06	4.04e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CCL5—multiple sclerosis	7.98e-06	4.04e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CCL5—multiple sclerosis	7.98e-06	4.04e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	7.98e-06	4.04e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—APOE—multiple sclerosis	7.83e-06	3.96e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—APOE—multiple sclerosis	7.83e-06	3.96e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—TYK2—multiple sclerosis	7.73e-06	3.91e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—TYK2—multiple sclerosis	7.73e-06	3.91e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—POMC—multiple sclerosis	7.72e-06	3.9e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—SPP1—multiple sclerosis	7.64e-06	3.87e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—IL2—multiple sclerosis	7.63e-06	3.86e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling by GPCR—IL6—multiple sclerosis	7.6e-06	3.84e-05	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—ALB—multiple sclerosis	7.57e-06	3.83e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—CCL2—multiple sclerosis	7.55e-06	3.82e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—IFNG—multiple sclerosis	7.48e-06	3.78e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CCR5—multiple sclerosis	7.44e-06	3.76e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—SPP1—multiple sclerosis	7.39e-06	3.74e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—SPP1—multiple sclerosis	7.39e-06	3.74e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—MAPK1—multiple sclerosis	7.39e-06	3.74e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—TYK2—multiple sclerosis	7.37e-06	3.73e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CD80—multiple sclerosis	7.33e-06	3.71e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IL2RA—multiple sclerosis	7.33e-06	3.71e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—IL2—multiple sclerosis	7.31e-06	3.7e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CD80—multiple sclerosis	7.31e-06	3.7e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling by GPCR—IL6—multiple sclerosis	7.27e-06	3.68e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—IL2—multiple sclerosis	7.27e-06	3.68e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CD80—multiple sclerosis	7.23e-06	3.66e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—IFNG—multiple sclerosis	7.23e-06	3.66e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—IFNG—multiple sclerosis	7.23e-06	3.66e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—MMP9—multiple sclerosis	7.23e-06	3.66e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—CD4—multiple sclerosis	7.22e-06	3.65e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	7.21e-06	3.65e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CCR5—multiple sclerosis	7.19e-06	3.64e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CCR5—multiple sclerosis	7.19e-06	3.64e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—POMC—multiple sclerosis	7.14e-06	3.61e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—TYK2—multiple sclerosis	7.13e-06	3.61e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—TYK2—multiple sclerosis	7.13e-06	3.61e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IL2RA—multiple sclerosis	7.09e-06	3.59e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IL2RA—multiple sclerosis	7.09e-06	3.59e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—APOE—multiple sclerosis	7.04e-06	3.56e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—IL2—multiple sclerosis	7.04e-06	3.56e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—IL2—multiple sclerosis	7.04e-06	3.56e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—POMC—multiple sclerosis	6.99e-06	3.54e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—CD4—multiple sclerosis	6.99e-06	3.53e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—CD4—multiple sclerosis	6.99e-06	3.53e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—POMC—multiple sclerosis	6.98e-06	3.53e-05	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—IL6—multiple sclerosis	6.96e-06	3.52e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—POMC—multiple sclerosis	6.96e-06	3.52e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—POMC—multiple sclerosis	6.95e-06	3.52e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—POMC—multiple sclerosis	6.94e-06	3.51e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—MMP9—multiple sclerosis	6.92e-06	3.5e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—IL2—multiple sclerosis	6.87e-06	3.48e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—POMC—multiple sclerosis	6.87e-06	3.48e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TYK2—multiple sclerosis	6.86e-06	3.47e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	6.86e-06	3.47e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling by GPCR—IL6—multiple sclerosis	6.84e-06	3.46e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CCL2—multiple sclerosis	6.81e-06	3.45e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CCL2—multiple sclerosis	6.79e-06	3.44e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—APOE—multiple sclerosis	6.77e-06	3.42e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	6.73e-06	3.4e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—POMC—multiple sclerosis	6.72e-06	3.4e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—POMC—multiple sclerosis	6.72e-06	3.4e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	6.71e-06	3.39e-05	CbGpPWpGaD
Nicardipine—CALM3—Innate Immune System—IL6—multiple sclerosis	6.71e-06	3.39e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—IL1B—multiple sclerosis	6.67e-06	3.37e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—CD4—multiple sclerosis	6.67e-06	3.37e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—MAPK1—multiple sclerosis	6.67e-06	3.37e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—IL2—multiple sclerosis	6.65e-06	3.36e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—MAPK1—multiple sclerosis	6.65e-06	3.36e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	6.58e-06	3.33e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	6.56e-06	3.32e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—APOE—multiple sclerosis	6.54e-06	3.31e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—APOE—multiple sclerosis	6.54e-06	3.31e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—ALB—multiple sclerosis	6.51e-06	3.29e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—MMP9—multiple sclerosis	6.51e-06	3.29e-05	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—IL6—multiple sclerosis	6.49e-06	3.28e-05	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—IL6—multiple sclerosis	6.49e-06	3.28e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—IL1B—multiple sclerosis	6.45e-06	3.26e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—IL1B—multiple sclerosis	6.45e-06	3.26e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—CD4—multiple sclerosis	6.45e-06	3.26e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—CD4—multiple sclerosis	6.45e-06	3.26e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—IL2—multiple sclerosis	6.43e-06	3.25e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—IL2—multiple sclerosis	6.43e-06	3.25e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—STAT3—multiple sclerosis	6.42e-06	3.25e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—ALB—multiple sclerosis	6.38e-06	3.23e-05	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—IL6—multiple sclerosis	6.37e-06	3.22e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—ALB—multiple sclerosis	6.36e-06	3.22e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—ALB—multiple sclerosis	6.34e-06	3.21e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—APOE—multiple sclerosis	6.28e-06	3.18e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—BCHE—multiple sclerosis	6.28e-06	3.18e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TYK2—multiple sclerosis	6.19e-06	3.13e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TYK2—multiple sclerosis	6.17e-06	3.12e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—STAT3—multiple sclerosis	6.15e-06	3.11e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—APOE—multiple sclerosis	6.13e-06	3.1e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—ALB—multiple sclerosis	6.13e-06	3.1e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—ALB—multiple sclerosis	6.13e-06	3.1e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CD80—multiple sclerosis	6.12e-06	3.09e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	6.11e-06	3.09e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	6.09e-06	3.08e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—POMC—multiple sclerosis	6.05e-06	3.06e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—MYC—multiple sclerosis	5.97e-06	3.02e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—TGFB1—multiple sclerosis	5.96e-06	3.01e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CD80—multiple sclerosis	5.92e-06	2.99e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CD80—multiple sclerosis	5.92e-06	2.99e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—MAPK1—multiple sclerosis	5.84e-06	2.95e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—POMC—multiple sclerosis	5.81e-06	2.94e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—STAT3—multiple sclerosis	5.78e-06	2.93e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—APOE—multiple sclerosis	5.78e-06	2.92e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—APOE—multiple sclerosis	5.73e-06	2.9e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—MYC—multiple sclerosis	5.72e-06	2.89e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—IL2—multiple sclerosis	5.71e-06	2.89e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—TGFB1—multiple sclerosis	5.7e-06	2.89e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CCL2—multiple sclerosis	5.69e-06	2.88e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—IL6—multiple sclerosis	5.68e-06	2.87e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—POMC—multiple sclerosis	5.62e-06	2.84e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—POMC—multiple sclerosis	5.62e-06	2.84e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—MAPK1—multiple sclerosis	5.59e-06	2.83e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—STAT3—multiple sclerosis	5.59e-06	2.83e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—MAPK1—multiple sclerosis	5.56e-06	2.81e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—ALB—multiple sclerosis	5.51e-06	2.79e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CCL2—multiple sclerosis	5.5e-06	2.78e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CCL2—multiple sclerosis	5.5e-06	2.78e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—STAT3—multiple sclerosis	5.41e-06	2.74e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—STAT3—multiple sclerosis	5.41e-06	2.74e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MMP9—multiple sclerosis	5.4e-06	2.73e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—POMC—multiple sclerosis	5.4e-06	2.73e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—MAPK1—multiple sclerosis	5.38e-06	2.72e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—MAPK1—multiple sclerosis	5.38e-06	2.72e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—MYC—multiple sclerosis	5.38e-06	2.72e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—TGFB1—multiple sclerosis	5.36e-06	2.71e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—POMC—multiple sclerosis	5.27e-06	2.66e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—MAPK1—multiple sclerosis	5.26e-06	2.66e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TYK2—multiple sclerosis	5.16e-06	2.61e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—STAT3—multiple sclerosis	5.16e-06	2.61e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—IL2—multiple sclerosis	5.15e-06	2.6e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—IL2—multiple sclerosis	5.13e-06	2.6e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—IL6—multiple sclerosis	5.12e-06	2.59e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—IL6—multiple sclerosis	5.11e-06	2.58e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—MAPK1—multiple sclerosis	5.08e-06	2.57e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—IL2—multiple sclerosis	5.08e-06	2.57e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	5.07e-06	2.56e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	5.06e-06	2.56e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	5.04e-06	2.55e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TYK2—multiple sclerosis	4.99e-06	2.53e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TYK2—multiple sclerosis	4.99e-06	2.53e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—STAT3—multiple sclerosis	4.99e-06	2.53e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—STAT3—multiple sclerosis	4.99e-06	2.53e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—POMC—multiple sclerosis	4.96e-06	2.51e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—POMC—multiple sclerosis	4.92e-06	2.49e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—ALB—multiple sclerosis	4.92e-06	2.49e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—MAPK1—multiple sclerosis	4.92e-06	2.49e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—MAPK1—multiple sclerosis	4.92e-06	2.49e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MMP9—multiple sclerosis	4.87e-06	2.47e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MMP9—multiple sclerosis	4.86e-06	2.46e-05	CbGpPWpGaD
Nicardipine—Clevidipine—BCHE—multiple sclerosis	4.82e-06	1	CrCbGaD
Nicardipine—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	4.81e-06	2.43e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—ALB—multiple sclerosis	4.8e-06	2.43e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—STAT3—multiple sclerosis	4.8e-06	2.43e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—MYC—multiple sclerosis	4.8e-06	2.43e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	4.8e-06	2.43e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—TGFB1—multiple sclerosis	4.79e-06	2.42e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—MAPK1—multiple sclerosis	4.69e-06	2.37e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—MYC—multiple sclerosis	4.64e-06	2.35e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—MYC—multiple sclerosis	4.64e-06	2.35e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—TGFB1—multiple sclerosis	4.63e-06	2.34e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—TGFB1—multiple sclerosis	4.63e-06	2.34e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—MAPK1—multiple sclerosis	4.54e-06	2.3e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—MAPK1—multiple sclerosis	4.54e-06	2.3e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—ALB—multiple sclerosis	4.53e-06	2.29e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—IL6—multiple sclerosis	4.49e-06	2.27e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—ALB—multiple sclerosis	4.49e-06	2.27e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MYC—multiple sclerosis	4.46e-06	2.26e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TGFB1—multiple sclerosis	4.45e-06	2.25e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MAPK1—multiple sclerosis	4.36e-06	2.21e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—STAT3—multiple sclerosis	4.33e-06	2.19e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—STAT3—multiple sclerosis	4.32e-06	2.18e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—IL6—multiple sclerosis	4.3e-06	2.17e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IL2—multiple sclerosis	4.3e-06	2.17e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	4.28e-06	2.16e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—IL6—multiple sclerosis	4.28e-06	2.16e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	4.26e-06	2.16e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IL2—multiple sclerosis	4.16e-06	2.1e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IL2—multiple sclerosis	4.16e-06	2.1e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—IL6—multiple sclerosis	4.14e-06	2.09e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—IL6—multiple sclerosis	4.14e-06	2.09e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MMP9—multiple sclerosis	4.07e-06	2.06e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—IL6—multiple sclerosis	4.04e-06	2.04e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MYC—multiple sclerosis	4.03e-06	2.04e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TGFB1—multiple sclerosis	4.02e-06	2.03e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MYC—multiple sclerosis	4.01e-06	2.03e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TGFB1—multiple sclerosis	4e-06	2.03e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MYC—multiple sclerosis	3.97e-06	2.01e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	3.96e-06	2.01e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	3.96e-06	2e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	3.95e-06	2e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MAPK1—multiple sclerosis	3.94e-06	1.99e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MMP9—multiple sclerosis	3.93e-06	1.99e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MMP9—multiple sclerosis	3.93e-06	1.99e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MAPK1—multiple sclerosis	3.93e-06	1.99e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—IL6—multiple sclerosis	3.91e-06	1.98e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	3.89e-06	1.97e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	3.88e-06	1.96e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—IL6—multiple sclerosis	3.78e-06	1.91e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—IL6—multiple sclerosis	3.78e-06	1.91e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—APOE—multiple sclerosis	3.78e-06	1.91e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—STAT3—multiple sclerosis	3.62e-06	1.83e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—IL6—multiple sclerosis	3.61e-06	1.82e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—STAT3—multiple sclerosis	3.5e-06	1.77e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—STAT3—multiple sclerosis	3.5e-06	1.77e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—IL6—multiple sclerosis	3.49e-06	1.76e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—IL6—multiple sclerosis	3.49e-06	1.76e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MYC—multiple sclerosis	3.36e-06	1.7e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—IL6—multiple sclerosis	3.35e-06	1.7e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TGFB1—multiple sclerosis	3.35e-06	1.7e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MAPK1—multiple sclerosis	3.29e-06	1.66e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MYC—multiple sclerosis	3.25e-06	1.64e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MYC—multiple sclerosis	3.25e-06	1.64e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—POMC—multiple sclerosis	3.25e-06	1.64e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TGFB1—multiple sclerosis	3.24e-06	1.64e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TGFB1—multiple sclerosis	3.24e-06	1.64e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MAPK1—multiple sclerosis	3.18e-06	1.61e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MAPK1—multiple sclerosis	3.18e-06	1.61e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—IL6—multiple sclerosis	3.03e-06	1.53e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—IL6—multiple sclerosis	3.02e-06	1.53e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—IL6—multiple sclerosis	2.99e-06	1.51e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	2.98e-06	1.51e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—ALB—multiple sclerosis	2.96e-06	1.5e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IL6—multiple sclerosis	2.53e-06	1.28e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IL6—multiple sclerosis	2.44e-06	1.24e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IL6—multiple sclerosis	2.44e-06	1.24e-05	CbGpPWpGaD
